PSA/PSMA DNA plasmid INO-5150

{
  "id": "MLC-T-ONC-016277",
  "term": "PSA/PSMA DNA plasmid INO-5150",
  "field": "Oncology and biomedicine",
  "definition": "A plasmid DNA vaccine encoding the tumor-associated antigens (TAAs) prostate-specific antigen (PSA) and prostate-specific membrane antigen (PSMA), with potential immunoactivating and antineoplastic activities. Upon intramuscular delivery and electroporation of the PSA/PSMA DNA plasmid INO-5150, both PSA and PSMA are translated in cells which then activate the immune system. This induces cytotoxic T-lymphocyte (CTL) responses against tumor cells expressing PSA and PSMA. This may result in both immune-mediated tumor cell death and the inhibition of tumor cell proliferation. PSA and PSMA are overexpressed on a variety of cancer cell types. The DNA encoding the TAAs in INO-5150 is based on both human and other primate antigen gene sequences. As the plasmid genes differ from the human gene sequences encoding these antigens, INO-5150 may overcome immune tolerance to human TAAs.",
  "synonyms": [
    "PSA/PSMA-encoding DNA plasmid INO-5150",
    "PSA/PSMA synthetic DNA vaccine INO-5150"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/psa-psma-dna-plasmid-ino-5150/"
}